TrialRespiratory research2021

InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.

Dave Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.